Howard Levy, Chief Medical Officer at CATALYST BIOSCIENCES, INC. (CBIO), bought 1,670 shares at $4.81 ($8K) on 2021-02-09, disclosed to the SEC on 2021-02-22.
Open-market purchase of $8k CBIO by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CBIO | BUY | 2020-03-17 | $10K | — | Filing → |
| CBIO | SELL | 2018-11-16 | $2K | — | Filing → |